Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Market Cap | $29,656 | $92,548 | $142,000 | $0 |
| - Cash | $18,537 | $40,656 | $5,778 | $563 |
| + Debt | $610 | $0 | $8,827 | $0 |
| Enterprise Value | $11,729 | $51,892 | $145,049 | -$563 |
| Revenue | $0 | $0 | $78 | – |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $78 | – |
| % Margin | – | – | 100% | – |
| EBITDA | -$24,632 | -$22,033 | -$9,665 | – |
| % Margin | – | – | -12,447.8% | – |
| Net Income | -$22,836 | -$22,266 | -$7,035 | – |
| % Margin | – | – | -9,061.1% | – |
| EPS Diluted | -0.071 | -0.072 | -0.022 | – |
| % Growth | 0.7% | -222.1% | – | – |
| Operating Cash Flow | -$22,211 | -$16,235 | -$4,249 | – |
| Capital Expenditures | -$29 | -$13 | -$71 | – |
| Free Cash Flow | -$22,240 | -$16,248 | -$4,320 | – |